Scientists Successfully Induce Endosymbiosis in Laboratory Conditions

CHSwitzerland|

In a groundbreaking study, researchers at the Swiss Federal Institute of Technology Zurich have successfully recreated the natural phenomenon of endosymbiosis, where one cellular organism lives within another. This marks the first time scientists have observed the early stages of this complex relationship in a controlled laboratory setting.

Endosymbiosis is a key driver of evolution and has led to the development of complex life forms. Notable examples include mitochondria in human cells, which originated as free-living bacteria, and the chloroplasts in plants. Despite its significance, scientists have grappled with understanding how such symbiotic partnerships originate and stabilize.

The researchers, led by Gabriel Giger and Julia Vorholt, experimented with the fungus Rhizopus microsporus and its bacterial associate Mycetohabitans rhizoxinica, known for producing toxins that aid the fungus in infecting rice plants. The team faced a significant challenge in squeezing the bacteria through the rigid cell wall of the fungus but ultimately developed a solution using enzymes and a syringe-like technique.

Upon successfully injecting M. rhizoxinica into the fungus, the researchers observed rapid growth and cooperation between the two organisms, indicating a stable partnership. Over successive generations, the researchers noted significant adaptations in both the fungus and the bacteria, reinforcing the idea that such symbiotic relationships can evolve quickly under the right conditions.

The findings have broader implications for understanding evolution and developing synthetic biology applications. Researchers believe that this achievement could lead to engineered organisms capable of performing specific functions, such as contaminant metabolism or medicinal production.

As further studies on endosymbiotic systems are planned, the potential for advancements in biological innovations continues to excite the scientific community.

Weekly Newsletter

Loading...

More from Switzerland

Scientists Discover Heavy Antimatter Particle at CERN, Shedding Light on Universe's Mysteries

Researchers at CERN's Large Hadron Collider have made a groundbreaking discovery of a particle named antihyperhelium-4, the heaviest antimatter particle identified to date. This finding, reported in a preprint on arXiv, could potentially illuminate the longstanding mystery of why our universe is predominantly composed of matter, despite theories suggesting an equal creation of matter and antimatter during the Big Bang. The discovery was made by the A Large Ion Collider Experiment (ALICE), which specializes in heavy-ion physics. The experiments recreate conditions akin to those present just one millionth of a second after the Big Bang. According to the researchers, antihyperhelium-4 consists of protons and neutrons along with hyperons containing “strange” quarks, making it fundamentally different from ordinary helium. Since hypernuclei decay rapidly, locating these particles poses significant challenges; only two other antihypernuclei have been identified in recent history. Qiu Hao, a collaborator with STAR at Brookhaven National Laboratory, emphasized the importance of creating and studying antimatter to unravel the mystery of matter-antimatter asymmetry in the universe.
CHSwitzerland

WHO Finalizes Historic Pandemic Accord Amid Global Urgency

After over three years of negotiations, member countries of the World Health Organization (WHO) have agreed on a landmark accord to enhance global preparedness for future pandemics. The deal, sealed early Wednesday at WHO headquarters in Geneva, aims to rectify the failures experienced during the COVID-19 crisis. WHO Director-General Tedros Adhanom Ghebreyesus hailed the agreement as a "significant milestone" in ensuring global health security. The final discussions occurred under the weight of new health threats, such as H5N1 bird flu and measles, and amidst concerns regarding cuts to U.S. foreign aid and potential tariffs on pharmaceuticals. Delegates overcame last-minute disagreements related to technology transfers intended for developing nations, with an emphasis on mutual agreements for such transfers. The 32-page accord introduces a Pathogen Access and Benefit-Sharing System to facilitate the rapid sharing of pathogen data with pharmaceutical companies, expediting research on pandemic-related products. The finalized text is set to be presented for official approval at the WHO's annual assembly next month.
CHSwitzerland

WHO Chief Warns of Imminent Pandemic Threat

During a recent World Health Organization (WHO) meeting, Director-General Dr. Tedros Adhanom Ghebreyesus warned that the next pandemic is inevitable and could emerge as soon as tomorrow. This statement reinforces the urgent need for global readiness, as many governments currently prioritize economic and geopolitical issues over pandemic preparedness. Dr. Ghebreyesus emphasized the importance of immediately addressing this looming challenge, reminding attendees that the COVID-19 pandemic resulted in over 20 million deaths and an estimated economic impact of $10 trillion. The WHO chief called for a legally binding international agreement that would ensure equitable access to resources and capabilities for pandemic response and management. Such an agreement would commit nations to collaborative approaches in safeguarding global health security, respecting national sovereignty while prioritizing collective readiness. He urged United Nations member states to expedite the finalization of this comprehensive framework, highlighting that the lessons learned from COVID-19 must not be ignored as the world braces for future health crises.
CHSwitzerland